Citation: | ZHANG Tian-chen, LIU Xiao-qing, PAN Huan-hong, ZHAO Yu-qin. rs12252 polymorphism of IFITM3 gene and influenza susceptibility in Chinese population: a study-based sequential Meta-analysis[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2019, 23(10): 1265-1272. doi: 10.16462/j.cnki.zhjbkz.2019.10.021 |
[1] |
Tanushree D, Amita J. Influenza virus: a brief overview[J]. Proc Natl Acad Sci Sect B Biol Sci, 2012, 82(1): 111-121. DOI: 10.1007/s40011-011-009-6.
|
[2] |
Fukuyama S, Kawaoka Y. The pathogenesis of influenza virus infections: the contributions of virus and host factors[J]. Curr Opin Immunol, 2011, 23(4): 481-486. DOI: 10.1016/j.coi.2011.07.016.
|
[3] |
Tscherne DM, Garcia-Sastre A. Virulence determinants of pandemic influenza viruses[J]. J Clin Invest, 2011, 121(1): 6-13. DOI: 10.1172/JCI44947.
|
[4] |
Wellington D, Laurenson-Schafer H, Abdel-Haq A, et al. IFITM3: how genetics influence influenza infection demographically[J]. Biomed J, 2019, 42(1): 19-26. DOI: 10.1016/j.bj.2019.01.004.
|
[5] |
Desai TM, Marin M, Chin CR, et al. IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion[J]. PLoS Pathog, 2014, 10(4): e1004048. DOI: 10.1371/journal.ppat.1004048.
|
[6] |
Wakim LM, Gupta N, Mintern JD, et al. Enhanced survival of lung tissue-resident memory CD8(+) T cells during infection with influenza virus due to selective expression of IFITM3[J]. Nat Immunol, 2013, 14(3): 238-245. DOI: 10.1038/ni.2525.
|
[7] |
Brass AL, Huang IC, Benita Y, et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, west nile virus, and dengue virus[J]. Cell, 2009, 139(7): 1243-1254. DOI: 10.1016/j.cell.2009.12.017.
|
[8] |
Randolph AG, Yip WK, Allen EK, et al. Evaluation of IFITM3 rs12252 association with severe pediatric influenza infection[J]. J Infect Dis, 2017, 216(1): 14-21. DOI: 10.1093/infdis/jix242.
|
[9] |
Williams DE, Wu WL, Grotefend CR, et al. IFITM3 polymorphism rs12252-C restricts influenza A viruses[J]. PLoS One, 2014, 9(10): e110096. DOI: 10.1371/journal.pone.0110096.
|
[10] |
Lee N, Cao B, Ke C, et al. IFITM3, TLR3, and CD55 gene SNPs and cumulative genetic risks for severe outcomes in Chinese patients with H7N9/H1N1pdm09 Influenza[J]. J Infect Dis, 2017, 216(1): 97-104. DOI: 10.1093/infdis/jix235.
|
[11] |
David S, Correia V, Antunes L, et al. Population genetics of IFITM3 in portugal and central africa reveals a potential modifier of influenza severity[J]. Immunogenetics, 2018, 70(3): 169-177. DOI: 10.1007/s00251-017-1026-2.
|
[12] |
Mehrbod P, Eybpoosh S, Fotouhi F, et al. Association of IFITM3 rs12252 polymorphisms, BMI, diabetes, and hypercholesterolemia with mild flu in an Iranian population[J]. Virol J, 2017, 14(1): 218. DOI: 10.1186/s12985-017-0884-4.
|
[13] |
Gaio V, Nunes B, Pechirra P, et al. Hospitalization risk due to respiratory illness associated with genetic variation at IFITM3 in patients with influenza A(H1N1)pdm09 infection: a case-control study[J]. PLoS One, 2016, 11(6): e0158181. DOI: 10.1371/journal.pone.0158181.
|
[14] |
López-Rodríguez M, Herrera-Ramos E, Solé-Violán J, et al. IFITM3 and severe influenza virus infection, no evidence of genetic association[J]. Eur J Clin Microbiol Infect Dis, 2016, 35(11): 1811-1817. DOI: 10.1007/s10096-016-2732-7.
|
[15] |
Mills TC, Rautanen A, Elliott KS, et al. IFITM3 and susceptibility to respiratory viral infections in the community[J]. J Infect Dis, 2014, 209(7): 1028-1031. DOI: 10.1093/infdis/jit468.
|
[16] |
Kim YC, Jeong BH. No Correlation of the disease severity of influenza A virus infection with the rs12252 polymorphism of the interferon-induced transmembrane protein 3 gene[J]. Intervirology, 2017, 60(1-2): 69-74. DOI: 10.1159/000479087.
|
[17] |
Carter TC, Hebbring SJ, Liu J, et al. Pilot screening study of targeted genetic polymorphisms for association with seasonal influenza hospital admission[J]. J Med Virol, 2018, 90(3): 436-446. DOI: 10.1002/jmv.24975.
|
[18] |
Wetterslev J, Thorlund K, Brok J, et al. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis[J]. J Clin Epidemiol, 2008, 61(1): 64-75. DOI: 10.1016/j.jclinepi.2007.03.013.
|
[19] |
郑建斌, 张剑珲, 陶建平, 等. 干扰素诱导跨膜蛋白3基因多态性与小儿流感严重程度相关性研究[J]. 生物医学工程学进展, 2016, 37(2): 66-69. DOI: 10.3969/j.issn.1674-1242.2016.02.002.
Zheng JB, Zhang JH, Tao JP, et al. Association of interferon inducible transmembrane protein 3 gene polymorphism with the severity of influenza in children[J]. Progress in Biomedical Engineering, 2016, 37(2): 66-69. DOI: 10.3969/j.issn.1674-1242.2016.02.002.
|
[20] |
朱乔伟. 干扰素诱导的跨膜蛋白3基因rs12252 T/C多态性与儿童流感遗传易患性和严重性的相关性研究[D]. 广州: 广州医学院, 2013.
Zhu QW. Correlation of rs12252 T/C polymorphism in the interferon induced transmembrane protein 3 gene and genetic susceptibility and severity in children with influenza[D]. Guangzhou: Guangzhou Medical College, 2013.
|
[21] |
潘阳, 杨鹏, 张奕, 等. 干扰素诱导跨膜蛋白3 rs12252多态性与乙型流感病毒感染相关性研究[J]. 国际病毒学杂志, 2016, 23(6): 364-367. DOI: 10.3760/cma.j.issn.1673-4092.2016.06.002.
Pan Y, Yang P, Zhang Y, et al. The association between IFITM3 rs12252 polymorphism and influenza B virus infection[J]. Int J Virol, 2016, 23(6): 364-367. DOI: 10.3760/cma.j.issn.1673-4092.2016.06.002.
|
[22] |
Zhang YH, Zhao Y, Li N, et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals[J]. Nat Commun, 2013, 4: 1418. DOI: 10.1038/ncomms2433.
|
[23] |
陈永坤, 朱闻斐, 郭俊峰, 等. 干扰素诱导跨膜蛋白3 rs12252单核苷酸多态性与乙型流感临床严重程度的相关性研究[J]. 病毒学报, 2017, 33(3): 389-393. DOI: 10.13242/j.cnki.bingduxuebao.003161.
Chen YK, Zhu WF, Guo JF, et al. The association between IFITM3 rs12252 gene polymorphism and severity of influenza B virus infection[J]. Chin J Virol, 2017, 33(3): 389-393. DOI: 10.13242/j.cnki.bingduxuebao.003161.
|
[24] |
Wang ZF, Zhang AL, Wan YM, et al. Early hypercytokinemia is associated with interferoninduced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection[J]. PNAS, 2014, 111(2): 769-774. DOI: 10.1073/pnas.1321748111.
|
[25] |
侯志飞, 赵学森. 干扰素诱导跨膜蛋白抗病毒机制研究进展[J/CD]. 中华实验和临床感染病杂志(电子版), 2018, 12(3): 212-215. DOI: 10.3877/cma.j.issn.1674-1358.2018.03.002.
Hou ZF, Zhao XS. Advances in antiviral study on interferon-induced transmembrane protein[J/CD]. Chin J Exp Clin Infect Dis (Electronic Edition), 2018, 12(3): 212-215. DOI: 10.3877/cma.j.issn.1674-1358.2018.03.002.
|
[26] |
Prabhu SS, Chakraborty TT, Kumar N, et al. Association between IFITM3 rs12252 polymorphism and influenza susceptibility and severity: a meta-analysis[J]. Gene, 2018(674): 70-79. DOI: 10.1016/j.gene.2018.06.070.
|
[27] |
Brass AL, Huang IC, Benita Y, et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, west nile virus, and dengue virus[J]. Cell, 2009, 139(7): 1243-1254. DOI: 10.1016/j.cell.2009.12.017.
|
[28] |
Schoggins JW, Wilson SJ, Panis M, et al. A diverse range of gene products are effectors of the type I interferon antiviral response[J]. Nature, 2011, 472(7344): 481-485. DOI: 10.1038/nature09907.
|
[29] |
Chen L, Borozan I, Feld J, et al. Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection[J]. Gastroenterology, 2005.128(5): 1437-1444. DOI: 10.1053/j.gastro.2005.01.059.
|
[30] |
Huang IC, Bailey CC, Weyer JL, et al. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus[J]. PLoS Pathog, 2011, 7(1): e1001258. DOI: 10.1371/journal.ppat.1001258.
|
[31] |
Wilkins C, Woodward J, Lau DT, et al. IFITM1 is a tight junction protein that inhibits hepatitis C virus entry[J]. Hepatology, 2013, 57(2): 461-469. DOI: 10.1002/hep.26066.
|
[32] |
Anafu AA, Bowen CH, Chin CR, et al. Interferon-inducible transmembrane protein 3(IFITM3) restricts reovirus cell entry[J]. J Biol Chem, 2013, 288(24): 17261-17271. DOI: 10.1074/jbc.M112.438515.
|
[33] |
Compton AA, Bruel T, Porrot F, et al. IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread[J]. Cell Host Microbe, 2014, 16(6): 736-47. DOI: 10.1016/j.chom.2014.11.001.
|
[34] |
Chan YK, Huang IC, Farzan M. IFITM proteins restrict antibody-dependent enhancement of dengue virus infection[J]. PLoS One, 2012, 7(3): e34508. DOI: 10.1371/journal.pone.0034508.
|
[35] |
Feeley EM, Sims JS, John SP, et al. IFITM3 inhibits influenza A virus infection by preventing cytosolic entry[J]. PLoS Pathog, 2011, 7(10): e1002337. DOI: 10.1371/journal.ppat.1002337.
|
[36] |
Ouyang J, Zhu X, Chen Y, et al. NRAV, a long noncoding RNA, modulates antiviral responses through suppression of interferon-stimulated gene transcription[J]. Cell Host Microbe, 2014, 16(5): 616-626. DOI: 10.1016/j.chom.2014.10.001.
|
[37] |
Everitt AR, Clare S, Pertel T, et al. IFITM3 restricts the morbidity and mortality associated with influenza[J]. Nature, 2012, 484(7395): 519-523. DOI: 10.1038/nature10921.
|
[38] |
Pan Y, Yang P, Dong T, et al. IFITM3 Rs12252-C Variant Increases Potential Risk for Severe Influenza Virus Infection in Chianese Population[J]. Front Cell Infect Microbiol, 2017, 7: 294. DOI: 10.3389/fcimb.2017.00294.
|